Prestige Consumer Healthcare (NYSE:PBH) Issues Earnings Results, Meets Expectations

Prestige Consumer Healthcare (NYSE:PBH) issued its earnings results on Thursday. The company reported $1.09 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.09, Briefing.com reports. The business had revenue of $283.79 million for the quarter, compared to analysts’ expectations of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The company’s quarterly revenue was down .9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.07 EPS. Prestige Consumer Healthcare updated its FY 2025 guidance to 4.460-4.460 EPS and its FY25 guidance to $4.40 to $4.46 EPS.

Prestige Consumer Healthcare Stock Performance

PBH stock traded up $0.28 during mid-day trading on Friday, reaching $80.37. 367,404 shares of the stock traded hands, compared to its average volume of 248,122. The firm has a market capitalization of $3.98 billion, a PE ratio of 19.58, a P/E/G ratio of 2.08 and a beta of 0.47. The business has a 50-day moving average of $72.43 and a two-hundred day moving average of $69.78. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. Prestige Consumer Healthcare has a 52 week low of $56.61 and a 52 week high of $81.25.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. DA Davidson raised their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, August 28th. Jefferies Financial Group reaffirmed a “hold” rating and set a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $94.20.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.